103 related articles for article (PubMed ID: 20662847)
41. A stepwise multimodality treatment of diffuse angiolymphoid hyperplasia of the orbit.
Krema H; El-Bolkainy N
Orbit; 2014 Feb; 33(1):75-7. PubMed ID: 24195724
[TBL] [Abstract][Full Text] [Related]
42. Successful treatment of acquired hemophilia a with rituximab and steroids in a 5-year-old girl.
Fletcher M; Crombet O; Morales-Arias J
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e103-4. PubMed ID: 23588328
[TBL] [Abstract][Full Text] [Related]
43. Orbital lymphoproliferative disorders.
Garner A
Br J Ophthalmol; 1992 Jan; 76(1):47-8. PubMed ID: 1739692
[No Abstract] [Full Text] [Related]
44. Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders.
Cerny J; Trneny M; Slavickova A; Pytlik R; Salkova J; Valkova V; Liu Q; Houghton J; Klener P
Hematology; 2009 Aug; 14(4):187-97. PubMed ID: 19635181
[TBL] [Abstract][Full Text] [Related]
45. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
Kojima M; Motoori T; Asano S; Nakamura S
Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
[TBL] [Abstract][Full Text] [Related]
46. Lymphoproliferative disorders of the orbit: an immunological approach to diagnosis and pathogenesis.
Garner A; Rahi AH; Wright JE
Br J Ophthalmol; 1983 Sep; 67(9):561-9. PubMed ID: 6603866
[TBL] [Abstract][Full Text] [Related]
47. Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis.
Heyes C; Nolan R; Leahy M; Gebauer K
Australas J Dermatol; 2012 Feb; 53(1):e1-4. PubMed ID: 22309343
[TBL] [Abstract][Full Text] [Related]
48. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
[TBL] [Abstract][Full Text] [Related]
49. [Clinical and pathological features of 112 cases with ocular adnexal lymphoproliferative lesions].
You QS; Li B; Zhou XG; Sun XL; An YZ; Shi JT; Li LQ; Gao F
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):871-6. PubMed ID: 16271169
[TBL] [Abstract][Full Text] [Related]
50. Rituximab in IgG4-related inflammatory disease of the orbit and ocular adnexae.
Lindfield D
Eye (Lond); 2012 Oct; 26(10):1386. PubMed ID: 22814806
[No Abstract] [Full Text] [Related]
51. Orbital manifestations of plasmacytic lymphoproliferations.
de Smet MD; Rootman J
Ophthalmology; 1987 Aug; 94(8):995-1003. PubMed ID: 3658377
[TBL] [Abstract][Full Text] [Related]
52. Treatment of idiopathic inflammatory orbital pseudotumours by radiotherapy.
Orcutt JC; Garner A; Henk JM; Wright JE
Br J Ophthalmol; 1983 Sep; 67(9):570-4. PubMed ID: 6411114
[TBL] [Abstract][Full Text] [Related]
53. Atypical lymphoid hyperplasia of the eyelids manifesting as xanthelasma-like lesions.
Egan CA; Patel BC; Morschbacher R; Gerwels JW; Anderson RL
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 2):839-42. PubMed ID: 9366848
[TBL] [Abstract][Full Text] [Related]
54. Bilateral benign reactive lymphoid hyperplasia of the conjunctiva: a case treated with oral doxycycline and review of the literature.
Klavdianou O; Kondylis G; Georgopoulos V; Palioura S
Eye Vis (Lond); 2019; 6():26. PubMed ID: 31497614
[TBL] [Abstract][Full Text] [Related]
55. Benign lymphoid hyperplasia of the palate.
Bradley G; Main JH; Birt BD; From L
J Oral Pathol; 1987 Jan; 16(1):18-26. PubMed ID: 3104564
[TBL] [Abstract][Full Text] [Related]
56. Benign nasopharyngeal lymphoid tumors, lymphoepithelial lesions, and lymphocytic interstitial pneumonitis.
Puterman M; Fliss DM; Goldstein J; Zirkin H
J Surg Oncol; 1988 Sep; 39(1):35-8. PubMed ID: 3419169
[TBL] [Abstract][Full Text] [Related]
57. Radiation therapy for B-cell cutaneous lymphoid hyperplasia.
Taylor RB; Fortney JA; Pollack RB; Metcalf JS; Jenrette JM
Jpn J Radiol; 2010 Jun; 28(5):385-7. PubMed ID: 20585929
[TBL] [Abstract][Full Text] [Related]
58. Treatment protocol for orbital inflammatory disease.
Leone CR; Lloyd WC
Ophthalmology; 1985 Oct; 92(10):1325-31. PubMed ID: 4069599
[TBL] [Abstract][Full Text] [Related]
59. Failure of radiation therapy in orbital xanthogranuloma.
Ebrahimi KB; Miller NR; Sassani JW; Iliff NT; Green WR
Ophthalmic Plast Reconstr Surg; 2010; 26(4):259-64. PubMed ID: 20502363
[TBL] [Abstract][Full Text] [Related]
60. Rituximab in Ocular Adnexal Lymphoma and Orbital Inflammatory Disease.
Deaner JD; Giacometti JN
Int Ophthalmol Clin; 2020; 60(2):63-75. PubMed ID: 32205654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
